Genesis Clinical Research, LLC ( Site 0003)
Tampa, Florida, United States
Research foundation in Tampa, Florida
2313 W Violet St, Tampa, FL 33603
About Genesis Clinical Research, LLC ( Site 0003)
"At Genesis Clinical research, we conduct research in a compassionate, professional setting. We strive to increase the quality of life in our patients and to provide the opportunity to access new drugs and medical treatments that may otherwise not be available."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Genesis Clinical Research, LLC ( Site 0003)
During the past decade, Genesis Clinical Research, LLC ( Site 0003) conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on
average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Pilot Study in Patients With Symptomatic Steroid-Naive Asthma
2001-08-01
2003-02-01
Completed
120
Study to Assess Efficacy of Tacrolimus + Methotrexate Versus Placebo + Methotrexate in Treatment of Rheumatoid Arthritis
2002-03-01
2004-01-01
Completed
210
An Investigational Drug (CAL) Versus Zoledronic Acid (Zometa®) in Patients With Breast Cancer
Completed
Humanized Anti-IL-2 Receptor Monoclonal Antibody in Moderate-to-severe Ulcerative Colitis
2003-04-01
2006-07-01
Completed
150
Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma
2002-05-01
2003-01-01
Completed
445
Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma
2002-12-01
2003-06-01
Completed
386
Dose-Ranging Study in Patients With Chronic Obstructive Pulmonary Disease (COPD)
2004-07-01
2004-12-01
Completed
686
Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease
2004-10-01
Completed
300
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Genesis Clinical Research, LLC ( Site 0003)" #1 sponsor was "Merck Sharp & Dohme LLC" with 2 trials, followed by "Abbott" with 1 trials
sponsored, "Amgen" with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "Sandoz"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Genesis Clinical Research, LLC ( Site 0003)"
#1 collaborator was "Duke Clinical Research Institute" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Genesis Clinical Research, LLC ( Site 0003)
According to Clinical.Site data, the most researched conditions in "Genesis Clinical Research, LLC ( Site 0003)" are
"ASCVD" (1 trials), "Anemia" (1 trials), "Chronic Kidney Disease (CKD)" (1 trials), "Diabetic Kidney Disease" (1 trials) and "End-Stage Renal Disease" (1 trials). Many other conditions were trialed in "Genesis Clinical Research, LLC ( Site 0003)" in a lesser frequency.
Clinical Trials Intervention Types at Genesis Clinical Research, LLC ( Site 0003)
Most popular intervention types in "Genesis Clinical Research, LLC ( Site 0003)" are "Drug" (5 trials). Other intervention types were less common.
The name of intervention was led by "BMS-813160" (1 trials), "HX575 epoetin alfa" (1 trials), "MK-2060" (1 trials), "Molnupiravir" (1 trials) and "Placebo matching with BMS-813160" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Genesis Clinical Research, LLC ( Site 0003)
The vast majority of trials in "Genesis Clinical Research, LLC ( Site 0003)" are
6 trials for "All" genders.
Clinical Trials Status at Genesis Clinical Research, LLC ( Site 0003)
Currently, there are NaN active trials in "Genesis Clinical Research, LLC ( Site 0003)".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Genesis Clinical Research, LLC ( Site 0003),
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Genesis Clinical Research, LLC ( Site 0003), 2 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".